JP2021519083A5 - - Google Patents

Info

Publication number
JP2021519083A5
JP2021519083A5 JP2020551860A JP2020551860A JP2021519083A5 JP 2021519083 A5 JP2021519083 A5 JP 2021519083A5 JP 2020551860 A JP2020551860 A JP 2020551860A JP 2020551860 A JP2020551860 A JP 2020551860A JP 2021519083 A5 JP2021519083 A5 JP 2021519083A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide
lysin
component
sequence
Prior art date
Application number
JP2020551860A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2019191633A5 (https=
JP2021519083A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/024912 external-priority patent/WO2019191633A2/en
Publication of JP2021519083A publication Critical patent/JP2021519083A/ja
Publication of JP2021519083A5 publication Critical patent/JP2021519083A5/ja
Publication of JPWO2019191633A5 publication Critical patent/JPWO2019191633A5/ja
Pending legal-status Critical Current

Links

JP2020551860A 2018-03-29 2019-03-29 溶解素−抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用 Pending JP2021519083A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201862650235P 2018-03-29 2018-03-29
US62/650,235 2018-03-29
US201862721969P 2018-08-23 2018-08-23
US62/721,969 2018-08-23
US201862722793P 2018-08-24 2018-08-24
US62/722,793 2018-08-24
PCT/US2019/024912 WO2019191633A2 (en) 2018-03-29 2019-03-29 Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof

Publications (3)

Publication Number Publication Date
JP2021519083A JP2021519083A (ja) 2021-08-10
JP2021519083A5 true JP2021519083A5 (https=) 2022-04-04
JPWO2019191633A5 JPWO2019191633A5 (https=) 2022-04-04

Family

ID=68060804

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020551860A Pending JP2021519083A (ja) 2018-03-29 2019-03-29 溶解素−抗微生物ペプチド(amp)ポリペプチドコンストラクト、溶解素、それをコードする単離ポリヌクレオチド及びその使用

Country Status (11)

Country Link
US (2) US11773140B2 (https=)
EP (1) EP3775192A4 (https=)
JP (1) JP2021519083A (https=)
KR (1) KR20200136980A (https=)
CN (1) CN112368376A (https=)
AU (1) AU2019245369A1 (https=)
BR (1) BR112020019484A2 (https=)
CA (1) CA3095484A1 (https=)
IL (1) IL277119B2 (https=)
MX (1) MX2020010075A (https=)
WO (1) WO2019191633A2 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015200783A2 (en) * 2014-06-26 2015-12-30 The Rockefeller University Acinetobacter lysins
WO2019118632A1 (en) 2017-12-12 2019-06-20 Contrafect Corporation Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US10988520B2 (en) * 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US20210330738A1 (en) * 2018-03-29 2021-10-28 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
CN114040773A (zh) * 2019-04-05 2022-02-11 康特拉费克特公司 在存在人血清的情况下对铜绿假单胞菌具有杀菌活性的溶素及其衍生物
KR20220029746A (ko) * 2019-07-05 2022-03-08 콘트라펙트 코포레이션 항미생물성 박테리오파지 유도된 폴리펩타이드 및 이의 그람 음성 및 항산성 세균에 대한 사용
EP4058468A4 (en) * 2019-11-14 2024-04-10 Contrafect Corporation POLYPEPTIDE CONSTRUCTIONS OF ANTIMICROBIAL PEPTIDE LYSINE (AMP), LYSINES, ISOLATED POLYNUCLEOTIDES ENCODING THEREFOR AND USES THEREOF
WO2021211303A1 (en) * 2020-04-14 2021-10-21 Contrafect Corporation Antiviral, bacteriophage-derived polypeptides and their use against viruses
US20210324359A1 (en) * 2020-04-17 2021-10-21 Contrafect Corporation Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis
KR20230162045A (ko) * 2021-03-26 2023-11-28 콘트라펙트 코포레이션 그램-음성 박테리아에 대해 활성인 아무린, 리신, 및 리신-항미생물 펩타이드 (amp) 작제물
WO2022236088A1 (en) * 2021-05-06 2022-11-10 Bioharmony Therapeutics Inc. Lysin polypeptide compositions and methods of use
FR3149209B1 (fr) * 2023-06-02 2026-04-03 Oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et un alcool aromatique
FR3149202B1 (fr) * 2023-06-02 2026-04-10 Oreal Composition cosmétique comprenant une endolysine dérivée de phage de Staphylococcus aureus et une huile.
EP4719330A1 (en) * 2023-06-02 2026-04-08 L'oreal Cosmetic composition comprising an endolysin derived from a staphylococcus aureus phage and an aromatic alcohol
FR3149203B1 (fr) * 2023-06-02 2026-03-13 Oreal Composition anhydre comprenant une endolysine et de l’hydroxypropylmethylcellulose et/ou du pullulane
WO2024256710A2 (en) 2023-06-15 2024-12-19 Aurobac Therapeutics Sas Engineered lysin polypeptide constructs active against gram-negative bacteria
WO2025054593A2 (en) * 2023-09-07 2025-03-13 The Trustees Of The University Of Pennsylvania Molecular de-extinction of antibiotics enabled by deep learning
CN120924524B (zh) * 2025-10-14 2026-01-06 中国海洋大学 一种抗菌肽及其制备方法和在制备治疗肺炎的制剂中的应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0517477A (pt) 2004-11-12 2008-10-07 Novozymes As polipeptìdeo, construção de ácido nucleico, vetor de expressão recombinante, célula hospedeira recombinante, métodos para produzir um polipeptìdeo, um polinucleotìdeo, e uma proteìna, planta, parte de planta ou célula vegetal transgênicas, método para matar ou inibir o crescimento de células microbianas, e, uso de um polipeptìdeo antimicrobiano
SG176783A1 (en) 2009-06-16 2012-01-30 Univ Tokai Anti-gram-negative bacteria agent
PL2445515T3 (pl) * 2009-06-26 2016-10-31 Środki przeciwdrobnoustrojowe
AU2010264659B2 (en) * 2009-06-26 2016-08-04 Lysando Aktiengesellschaft Antimicrobial agents
KR20120059576A (ko) 2009-08-24 2012-06-08 뤼산도 홀딩 아게 신규한 엔도리신 OBPgpLYS
EP2468856A1 (en) 2010-12-23 2012-06-27 Lysando Aktiengesellschaft Antimicrobial Agents
EP2699689A4 (en) 2011-04-21 2014-12-17 Univ Utrecht Holding Bv STREPTOCOCCUS BACTERIOPHAGEN LYSINE FOR THE TREATMENT OF GRAM-POSITIVE BACTERIA IN PETS AND UTILITIES
EP2702070B1 (en) 2011-04-27 2015-09-30 Lysando AG New antimicrobial agents
WO2012159774A1 (en) 2011-05-26 2012-11-29 Dsm Ip Assets B.V. Novel listeria bacteriophage p825n and uses thereof
US8790639B2 (en) 2012-03-28 2014-07-29 The United States Of America, As Represented By The Secretary Of Agriculture Enhanced antimicrobial lytic activity of a chimeric Ply187 endolysin
KR101391332B1 (ko) 2012-05-18 2014-05-07 연세대학교 산학협력단 카바페넴 제제에 내성을 보이는 아시네토박터 속의 균을 용균하는 박테리오파아지
US9388400B2 (en) * 2012-06-29 2016-07-12 Lysando Ag Composition for use in mycobacteria diagnosis
CN102861324A (zh) * 2012-10-17 2013-01-09 重庆市第三人民医院 治疗耐碳青霉烯类鲍曼不动杆菌感染的生物试剂
WO2015200783A2 (en) 2014-06-26 2015-12-30 The Rockefeller University Acinetobacter lysins
EP4115897A1 (en) 2015-09-17 2023-01-11 Contrafect Corporation Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
KR102000120B1 (ko) 2017-01-26 2019-07-15 주식회사 코미팜 이유 자돈의 대장균증을 예방하기 위한 재조합 p22 라이소자임 - pmap36 융합 단백질을 이용한 장내독소형 대장균(etec) 고스트 백신 조성물
WO2019118632A1 (en) 2017-12-12 2019-06-20 Contrafect Corporation Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa
US20210330738A1 (en) 2018-03-29 2021-10-28 Contrafect Corporation Antimicrobial, bacteriophage-derived polypeptides and their use against gram-negative bacteria
WO2019191633A2 (en) 2018-03-29 2019-10-03 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US10988520B2 (en) 2018-03-29 2021-04-27 Contrafect Corporation Lysin-antimicrobial peptide (AMP) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
EP3840771A4 (en) * 2018-08-23 2023-04-19 Contrafect Corporation Lysin-antimicrobial peptide (amp) polypeptide constructs, lysins, isolated polynucleotides encoding same and uses thereof
US20210324359A1 (en) * 2020-04-17 2021-10-21 Contrafect Corporation Use of gram-negative lysin-antimicrobial peptide (amp) polypeptide constructs in treating endocarditis

Similar Documents

Publication Publication Date Title
JP2021519083A5 (https=)
IL277119B1 (en) Antimicrobial lysine-peptide polypeptide templates, lysines, isolated polynucleotides encoding them and uses thereof
JP2021506769A5 (https=)
JP2024010053A5 (https=)
US12144845B2 (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
JPWO2019191633A5 (https=)
US11690899B2 (en) Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
JP2021533728A5 (https=)
JP2024010053A (ja) シュードモナス・エルギノーサに対する殺菌活性を有する溶解素及びその誘導体の特定
JP2021519311A5 (https=)
RU2020128276A (ru) МОДИФИЦИРОВАННЫЕ ЛИЗИНЫ PlySs2 И ВАРИАНТЫ ИХ ПРИМЕНЕНИЯ
US20220160843A1 (en) Lysins and derivatives thereof with bactericidal activity against pseudomonas aeruginosa, in the presence of human serum
JPWO2021180892A5 (https=)
JPWO2020206327A5 (https=)
JPWO2021097192A5 (https=)
US12606640B2 (en) Recombinant antimicrobial multidomain polypeptide, methods of producing and uses thereof
HK40086790A (en) Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby
RU2022126282A (ru) Новый рекомбинантный лизин и его применение в лечении грамотрицательных бактериальных инфекций
RU2021128336A (ru) Лизины и их производные с бактерицидной активностью против pseudomonas aeruginosa в присутствии сыворотки крови человека